Informed Consent and Decision Making Among Participants in Novel-Design Phase I Oncology Trials.

Abstract

BACKGROUND Although phase I clinical trials are the gateway to progress in cancer therapies, this setting poses ethical challenges to ensure that patients provide consent free from misunderstandings of therapeutic intent or unrealistic expectations of benefit. The design of phase I oncology trials has evolved rapidly over time and today includes more… (More)
DOI: 10.1200/JOP.2017.021303

Topics

  • Presentations referencing similar topics